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Background. The present study is to look for a correlation between oxidative stress and thyroid function in patients with the
nephrotic syndrome in the remission phase as well as in a persistent proteinuric state. Introduction. Nephrotic syndrome is a
form of chronic kidney disease due to which blood loses protein through the urine. We wanted to know if there was an increased
loss of thyroid hormones in urine aﬀecting thyroid function. Methods. 60 patients with nephrotic syndrome and 20 healthy
non-proteinuric individuals as control subjects were enrolled in the study. We measured their serum tri-iodothyronine, thyroxine
and thyroid-stimulating hormone. Estimation of lipid peroxidation (LPx) catalase, superoxide dismutase (SOD), and Glutathione
peroxidase (GPx) were carried out by standard methods. Results. TSH was elevated in the nephrotic patients compared to controls,
while TT4 and TT3 were signiﬁcantly lower in the patients than in controls. Lipid Peroxidation and GPx were signiﬁcantly higher
in the nephrotic syndrome patients than in the controls, while SOD and catalase were signiﬁcantly lower than in patients than
in the control subjects. Conclusion. Nephrotic patients can lose signiﬁcant amounts of thyroid hormones along with protein in
urine, which can aﬀect thyroid status, but this is reversible on remission.
1.Introduction
Nephrotic syndrome results in loss of plasma proteins
and various other macromolecules in the urine leading to
their deﬁciencies. Many of the physiologically important
molecules which exist in the plasma, bound to plasma
proteins, are also carried away and are lost in the urine
[1]. The common abnormalities arising as a result of heavy
proteinuria include hypothyroidism, vitamin D deﬁciency,
andirondeﬁciency.Whileurinarylossofvitamin-D-binding
globulin and transferrin accounts for their respective
deﬁciencies, the exact cause of hypothyroidism in nephrotic
syndromeappearstobecomplex.Initiallyitwasthoughtthat
these individuals are metabolically euthyroid, as evidenced
bytheirnormalplasmafreeT4(FT4)levelsandfreeT3(FT3)
levels. The decrease in total T4 (TT4) was often attributed
to the urinary loss of Thyroid Binding Globulin (TBG) and
the resulting increase in unbound hormone suppressing
further thyroid hormone secretion from the gland. As the
thyroid gland function is regulated by thyroid-stimulating
hormone (TSH) secreted from the pituitary gland, the levels
of this hormone are expected to be low in the above case.
However TSH levels were found to be very high in nephrotic
syndrome and the increase in TSH correlates well with
the degree of proteinuria. This leads to the possibility that
signiﬁcant amounts of thyroid hormones are also lost in
proteinuric states resulting in a total body negative balance.
In situations of long standing heavy proteinuria, it results in
clinically signiﬁcant hypothyroidism.
Whether the hypothyroidism of nephrotic syndrome
remains an innocent bystander or plays an active part in
the further course of the disease is yet to be understood.
In most glomerular diseases, the renal injury is largely
initiated by immunological mechanisms. However, once the
injury is inﬂicted, subsequent progression to glomeruloscle-
rosis and renal failure is mediated by nonimmunological
factors like intraglomerular and systemic hypertension,
tubuloglomerular feedback, glomerular hypertrophy and2 International Journal of Nephrology
hyperﬁltration, proteinuria, hyperlipidemia, and presence
of extra renal disease. In recent years, researchers have
been looking at reactive oxygen species (ROS) or oxida-
tive stress as mediators of progressive glomerular injury
[2–4].
RenalsourcesofROSareactivatedmacrophages,vascular
cells, and various glomerular cells. ROS may aﬀect cells of
the host organism, especially at sites of inﬂammation, in
addition to playing a role in the defence system against other
agents. The eﬀect plays a role in a variety of renal diseases
such as glomerulonephritis and tubulointerstitial nephritis,
which can contribute to porteinuria and other conditions.
ROS are also thought to contribute to the pathogenesis of
ischemia reperfusion injury in the kidney [5, 6].
Thyroid hormones (THs) are essential for normal
metabolic function of the kidneys. Conversely, the kidney
is not only an organ for metabolism and elimination of
TH but also a target organ of some of the iodothyronines’
actions. Thyroid dysfunction causes remarkable changes in
glomerular and tubular functions and electrolyte and water
homeostasis. Hypothyroidism is accompanied by a decrease
in glomerular ﬁltration, hyponatremia, and an alteration of
the ability for water excretion [7–9].
Hypertension, diabetes, and proteinuria are well-recog-
nized risk factors for progressive kidney function loss. How-
ever, despite excellent antihypertensive and antidiabetic drug
therapies, which also often lower urinary protein excretion,
there remains a signiﬁcant reservoir of patients with chronic
kidney disease who are at high risk for progression to end-
stage kidney disease [10].
In order to ascertain whether the hypothyroidism of
nephrotic syndrome has any role to play in glomeruloscle-
rosis, we decided to estimate the thyroid hormone levels
and markers of oxidative stress in patients with nephrotic
syndrome, those in complete or partial remission and in
healthy control subjects. We also tried to evaluate the
correlation between oxidative stress and thyroid function in
patients with the nephrotic syndrome in the remission phase
as well as in a persistent proteinuric state (Figure 1).
2.Materials
The present study was carried out in the Radiation Medicine
Centre, Bhabha Atomic Research Centre (BARC), Mumbai,
in collaboration with the Department of Nephrology, King
Edward VII Memorial Hospital (KEM), Parel, Mumbai. Suf-
ﬁcient and necessary Hospital Ethics Committee approvals
from both institutions were taken.
A total of 80 subjects were enrolled in the study of
whom 60 patients included in the patients were either in
complete remission or had persistent proteinuria at the time
of the study and 20 normotensive, nonproteinuric, healthy
individuals formed the control group.
The inclusion criteria were (A) Age between 12 and 50
years, (B) Documented nephrotic syndrome (deﬁned as pro-
teinuria of more than 3.5gm/24hr/1.73m2 and (C) body
surface area or any proteinuria associated with signiﬁcant
hypoalbuminemia, deﬁned as serum albumin less than
2.5gm/dL) at the time of enrolment to the study.
Thyroid hormones
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Figure 1: Eﬀects of thyroid hormones on the kidney [11].
Regrouping of the 80 subjects, based on their 24-hour
urinary protein excretion, the subjects were divided into
four groups, control (0.15gms/24h), remission (0.09 ±
0.03gms/24h), subnephrotic (1.22 ± 0.90gms/24h) and
nephrotic (5.07 ± 1.36gms/24h).
Both the patient and the control groups underwent
a detailed study of history recording followed by com-
plete physical examination with the purpose of ruling out
secondary causes of glomerulonephritis and evidence of
any systemic illness or infective focus. Routine laboratory
investigations were done at K.E.M. Hospital.
Nephrotic syndrome occurring as a part of systemic
disease such as diabetes mellitus, active infection, sepsis,
smoking, alcoholism, and drug abuse and patients who had
received steroids or immunosuppressant drugs within the 6-
month period before enrolment were included the study.
3. Methods
Westudiedthyroidfunctionandestimated(a)tri-iodothyro-
nine (T3), (b) thyroxine (T4) by radioimmunoassay (RIA),
and (c) thyroid-stimulating hormone (TSH) by immunora-
diometric assay (IRMA) using in-house methods for T3 and
T4 assays and BRIT kits for TSH.
Estimation of lipid peroxidation (LPx) and antioxidant
enzymes (superoxide dismutase (SOD), glutathione peroxi-
dase (GPx), and catalase) in serum samples was as follows.
(A) Malondialdehydecontent,theendproductofthefree
radicals initiating lipid peroxidation, was measured
by using thiobarbituric acid reactivity as described by
Uchiyama and Mihara [12].
(B) SOD was measured by the method of S. Marklund
and G. Marklund [13] as modiﬁed by Nandi and
Chatterjee [14]. Superoxide anion radical is involved
in the autooxidation of alkaline pyrogallol.
(C) The catalase activity was estimated by the method of
Aebi [15]. Catalase degrades hydrogen peroxide,International Journal of Nephrology 3
Table 1: Parameters of oxidative stress in nephrotic syndrome.
Group Lipid Peroxidation
nmMDA/mL
Superoxide Dismutase
(SOD)U/mL Catalase U/mL Glutathione Peroxidase
(GPx)U/mL
Control (N = 20) 1.5 ± 0.31 7.2 ± 2.7 2.3 ± 1.6 616 ± 163
Remission (N = 20) 1.4 ± 0.83 7.4 ± 3.2 4.7 ± 2.8∗ 664 ± 283∗
Subnephrotic (N = 20) 1.7 ± 0.85∗ 6.6 ± 2.5∗ 3.6 ± 2.2∗ 675 ± 233∗
Nephrotic (N = 20) 2.0 ± 1.4∗ 6.0 ± 2.1∗ 2.9 ± 1.9∗ 676 ± 398∗
∗P < 0.001.
0
2
4
6
8
10
12
LPx SOD CAT GPxX100
S
e
r
u
m
a
c
t
i
v
i
t
y
(
u
n
i
t
/
m
L
)
Control
Remission Nephrotic
Subnephrotic
Figure 2: Parameters of oxidative stress in control, remission, sub-
nephrotic, and nephrotic Groups.
which can be determined by the decrease in absor-
bance at 240nm in a spectrophotometer.
(D) GPx activity was analyzed by the method of Hafeman
et al., based on the consumption of GSH [16]. Glu-
tathione peroxidase degrades tertiary butyl hydro-
peroxide in the presence of GSH.
4. Results
4.1. Parameters of Oxidative Stress. All the parameters of
antioxidant enzymes and lipid peroxidation are summarized
in Table 1,a n db a rg r a p h si nFigure 2 depict the parameters
of oxidative stress in nephrotic syndrome.
The serum LPX levels the were lowest in the remission
and subnephrotic groups with signiﬁcantly maximum value
in the nephrotic group.
Serum GPx was signiﬁcantly higher in all the three
groups in comparison to control group.
The serum SOD levels were signiﬁcantly lower in the
subnephroticandnephroticgroupsincomparisontocontrol
group, and also Catalase levels were signiﬁcantly higher in all
three groups in comparison to control with the minimum
value in the nephrotic group.
4.2. Parameters of Thyroid Function Test. The estimates of
TT3, TT4, and TSH are summarized in Table 2.
A sc a nb es e e ni nTable 2, TT3 and TT4 levels were
signiﬁcantly lower and TSH was signiﬁcantly higher in
nephrotic syndrome than control group.
4.3. Statistically Analysis. All results are expressed as the
mean ± SD. The data between control and test groups was
compared using unpaired Student’s t-test. Correlation was
determined by Pearson’s correlation coeﬃcient. The level of
signiﬁcance used was P value less than 0.001.
4.4. The Results. The balance of reduction and oxidation
(redox) of free radicals in the body is important to maintain
health.
The Data suggest that the endogenous antioxidant
enzymes serve as a mechanism of self-defense to prevent
glomerular injury.
Superoxide dismutase enzyme is involved in catalyzing
superoxide anion-free radical to produce hydrogen peroxide
and singlet oxygen.
We have observed the decrease in SOD activity in
nephrotic syndrome patients because superoxide anion
produced during normal metabolic process could not be
completely scavenged by the SOD. It is quite possible that it
may accumulate and cause the initiation and propagation of
lipid peroxides.
A decreased production of H2O2 would result in
increased activity of catalase enzymes since hydrogen perox-
ide is hydrolyzed by catalase.
Both superoxide free radical and hydroperoxides can
be generated within cells and could cause irreversiblility in
activation of GSH peroxidase. GSH peroxidase functions to
metabolize H2O2 created in the dismutation of superoxide
radical and protects cell membranes for lipid peroxidation.
The serum levels of thyroid hormones were signiﬁcantly
lower in nephrotic patients compared to control, while the
serum TSH levels were signiﬁcantly higher as expected due
to pituitary’s response to the decreased hormone levels.
5. Discussion
Nephrotic syndrome is accompanied by changes in the
concentrations of TH due primarily to loss of protein in
the urine. Acute kidney injury and chronic kidney disease
are accompanied by notable eﬀects on the hypothalamus-
pituitary-thyroid axis. Finally, data from a recent research4 International Journal of Nephrology
Table 2: Urinary protein and thyroid hormone levels in nephrotic syndrome.
Group Proteinuria (g/24hrs.) TT4 (µg/dL) TT3 (ng/dL) TSH (µIU/mL)
Control (N = 20) <150 9.9 ± 2.6 130 ± 36 2.9 ± 1.2
Remission (N = 20) 111 ± 34 8.1 ± 2.9 132 ± 35 2.8 ± 1.3
Subnephrotic (N = 20) 1242 ± 898∗ 8.4 ± 1.5 119 ± 20 2.7 ± 1.0
Nephrotic (N = 20) 5137 ± 1282∗ 5.8 ± 1.6∗ 55 ± 30∗ 5.9 ± 1.8∗
∗P < 0.001.
suggest that TH, especially T3, can be considered as a marker
for survival in patients with kidney disease [17].
Nephroticsyndromeisassociatedwithanoverallincrease
in oxidative stress. There is a concomitant statistically
signiﬁcant decrease in circulation of T4 and T3 levels and
increase in serum TSH. The nature and severity of the
original insult may possibly play role in contributing to the
oxidative stress associated with nephrotic syndrome. Other
than the decrease in thyroid function due to nephrotic
syndrome (a form of nonthyroid illness), loss of thyroid-
hormone-binding proteins in urine could be another cause
of the decrease in serum T3 and T4 levels.
Bulucu et al. have studied the oxidative stress status in
adult nephrotic syndrome by determining plasma selenium
levels, erythrocyte and plasma GPx activities, erythrocyte
Cu-Zn SOD, and erythrocyte and plasma levels of mal-
ondialdehyde (MDA). The 20 nephrotic syndrome patients
had lower activities of SOD compared to controls, while
erythrocyte and plasma levels of MDA were higher in the
nephrotic syndrome groups [18].
Zachwieja et al. studied the total antioxidant status and
mean antioxidant activity in 82 children with nephrotic
syndrome of 4–16 years. The study suggested that reduced
antioxidant activity in nephrotic syndrome may be related to
lipid abnormalities [19].
Fydryk et al. examined the antioxidant status of 18
children with steroid sensitive nephrotic syndrome. In their
study, the authors concluded that the majority of abnormal
ﬁndingscanbeattributedtothehyperlipidemiaofnephrotic
syndreme(NS).LowGPxactivitymaybeafactorlimitingthe
antioxdiant capacity in NS [10].
Another study estimated the antioxidant status and
reliable factor involved in antioxidant protection in children
with nephrotic syndrome. The study suggested an increase
in lipid peroxidation and insuﬃcient antioxidant defense in
Nephrotic syndrome [20].
The author concluded that, during remission, there is a
tendency for the GSH-GSSG redox system to normalize [21].
Gilles et al. reported that abnormalities in thyroid func-
tion are seen in patients with proteinuria. Speciﬁcally, TSH
levels were higher in patients with proteinuric renal diseases
when compared with controls. Subclinical hypothyroidism
occurred more frequently in the nephritic syndrome patients
[22].
Adlkofer et al. examined the thyroid function of 13
patients with proteinuria and normal serum creatinine level
(Group 1) and 15 patients with proteinuria and increased
creatinine level (Group 2). The daily urinary T4 and T3
excretion was much higher in Group 1 patients than in
Group 2 patients (37.1 ± 25.9nmol versus 17.5 ± 8.7nmol
forT4and3.3 ±1.6nmolversus1.1 ±0.8nmolforT3,resp.)
and correlated in both groups with the protein loss [23].
Feinstein et al. showed that the reduced serum levels of
TT4 and TT3 in these patients may be due to decreased
binding to and/or concentration of serum carrier proteins,
and, as in acute and chronic renal failure, patients with
nephroticsyndromewithnormalrenalfunctionhavenormal
total and increased free rT3 values in association with
reduced TT3 levels [24].
Hypothyroidism is also known to be accompanied by
a decrease in glomerular ﬁltration, hyponatremia, and an
alteration of the ability for water excretion, which may
indirectly reduce loss of protein through urine [7–9].
6. Conclusion
In hypothyroidism, thyroid hormone levels are very low,
which suggests the possible direct involvement of free radical
scavengers and lipid peroxidation. Increased glutathione
peroxidase activity could be a compensatory mechanism in
response to increased oxidative stress [25, 26].
Our ﬁnding suggests that nephrotic syndrome patients
have an increased risk of subclinical hypothyroidism. Thy-
roid hormones accelerate the basal metabolic rate and more
especiallyoxidativemetabolisminvertebrates.Excessthyroid
hormones may induce tissue injury secondary to production
of active oxygen species. Thyroid function returns to the
normal when the nonthyroid illness is resolved [27].
Proteinuria results in loss of thyroid hormones, most
probably caused by loss of thyroxine-binding globulin along
with T4 bound to it, thus stimulating TSH production [4].
Our data suggests that nephrotic syndrome patients
may beneﬁt from antioxidant therapy along with thyroid
hormone supplement.
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